This document is an excerpt from the EUR-Lex website
Document 31992L0028
National transposition measures communicated by the Member States concerning:
Council Directive 92/28/EEC of 31 March 1992 on the advertising of medicinal products for human use
OJ L 113, 30/04/1992, p. 13–18
(ES, DA, DE, EL, EN, FR, IT, NL, PT) This document has been published in a special edition(s)
(FI, SV)
The member states bear sole responsibility for all information on this site provided by them on the transposition of EU law into national law. This does not, however, prejudice the results of the verification by the Commission of the completeness and correctness of the transposition of EU law into national law as formally notified to it by the member states. The collection National transposition measures is updated weekly.
Bekendtgørelse nr. 328 af 24/05/1993
Bekendtgørelse nr. 329 af 24/05/1993
Décision ministérielle numéro Y6A/776/1993 du 23/06/1993. FEK numéro 536 du 20/07/1993 Page 5847
Correction des erratas Décision ministérielle. FEK numéro 745 du 27/09/1993 Page 7841
Wijziging Regeling bloedproducten van 12/09/1997, Staatscourant nummer 179 van 18/09/1997
Lääkelaki (395/87) 10/04/1987, muutos (1046/93) 26/11/1993
Läkemedelslag, Svensk författningssamling SFS) 1992:859
Läkemedelsförordning, Svensk författningssamling SFS) 1992:1752
The Medicines (Advertising) Regulations 1994. Statutory Instruments number 1932 of 1994